Characterization of a chemoattractant for endothelium induced by angiogenesis effectors.
The mechanism of neovascularization was further explored by the use of chemically defined angiogenesis effectors. The vascularization of the rabbit cornea was selected as an experimental approach that permits comparison of one cornea treated by the angiogenesis effector with the contralateral cornea of the same subject treated by the same molecule deprived of angiogenic capacity. Under these conditions, we observed that neovascularization was initiated by the appearance of a chemoattractant for the bovine capillary endothelium only in the cornea treated by the angiogenesis effector. The chemoattractant was purified about 150-fold by a single-step procedure, using gelatin:Sepharose affinity chromatography. Chemoattraction resulted from the combined effect of a chemotactic factor(s) and an activating factor(s). The association of the two enhanced 5- to 8-fold the motility of the capillary endothelium in a concentration-dependent manner with optimum at 0.2 mg/ml. The activating factor(s) does not have chemotactic capacity, but without it, chemotaxis is reduced to about one half. The chemotactic complex was present in the cornea regardless of the nature of the angiogenesis effector used as the triggering device. Heat and proteases eliminated chemotaxis and destroyed the chemotactic complex. Thus, neovascularization may be triggered by effectors able to induce in the cornea proteins, normally not present, that influence angiogenesis via mobilization of capillary endothelium.
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology; D000818:Animals; D002196:Capillaries / Q000502:physiology; D002417:Cattle; D002478:Cells, Cultured; D002570:Ceruloplasmin / Q000494:pharmacology; D002633:Chemotaxis / Q000187:drug effects*; D003300:Copper / Q000494:pharmacology*; D003315:Cornea / Q000098:blood supply*; D004727:Endothelium / Q000187:drug effects / Q000502:physiology; D005260:Female; D007700:Kinetics; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D009842:Oligopeptides / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012879:Skin Physiological Phenomena; D014020:Tissue Extracts / Q000494:pharmacology
D043925:Angiogenesis Inducing Agents; D009842:Oligopeptides; D011458:Prostaglandins E; D014020:Tissue Extracts; C020905:glycyl-histidyl-lysine; D003300:Copper; D002570:Ceruloplasmin